Optimizing Platelet and Leucocyte-Rich Plasma as Biomaterials for Ophthalmic Applications: Impact of Centrifugation Speed

References

• Nikolidakis D, Jansen JA. The biology of platelet-rich plasma and its application in oral surgery: literature review. Tissue Eng Part B Rev. 2008;14(3):249–258. doi:10.1089/ten.teb.2008.0062
   PubMed Web of Science ®Google Scholar
• Acebes-Huerta A, Arias-Fernández T, Bernardo Á, et al. Platelet-derived bio-products: classification update, applications, concerns and new perspectives. Transfus Apher Sci. 2020;59(1):102716. doi:10.1016/j.transci.2019.102716
   PubMed Web of Science ®Google Scholar
• Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Haemost. 2011;105(SUPPL. 1):S13–33. doi:10.1160/THS10-11-0720
   PubMed Web of Science ®Google Scholar
• Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009;37(11):2259–2272. doi:10.1177/0363546509349921
   PubMed Web of Science ®Google Scholar
• Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454(7203):428–435. doi:10.1038/nature07201
   PubMed Web of Science ®Google Scholar
• Andrae J, Gallini R, Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 2008;22(10):1276–1312. doi:10.1101/gad.1653708
   PubMed Web of Science ®Google Scholar
• Alio JL, Rodriguez AE, WróbelDudzińska D. Eye platelet-rich plasma in the treatment of ocular surface disorders. Curr Opin Ophthalmol. 2015;26(4):325–332. doi:10.1097/ICU.0000000000000169
   PubMed Web of Science ®Google Scholar
• Alio JL, Abad M, Artola A, Rodriguez-Prats JL, Pastor S, Ruiz-Colecha J. Use of autologous platelet-rich plasma in the treatment of dormant corneal ulcers. Ophthalmology. 2007;114(7):1286–1294. doi:10.1016/j.ophtha.2006.10.044
   PubMed Web of Science ®Google Scholar
• Anitua E, Sanchez M, Nurden AT, Nurden P, Orive G, Andia I. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol. 2006;24:227–234. doi:10.1016/j.tibtech.2006.02.010
   PubMed Web of Science ®Google Scholar
• Merolle L, Iotti B, Berni P, et al. Platelet-rich plasma lysate for treatment of eye surface diseases. J Vis Exp. 2022;186:3791/63772.
   Google Scholar
• Devereaux J, Dargahi N, Fraser S, Nurgali K, Kiatos D, Apostolopoulos V. Leucocyte-rich platelet-rich plasma enhances fibroblast and extracellular matrix activity: implications in wound healing. Int J Mol Sci. 2020;21(18):6519. doi:10.3390/ijms21186519
   PubMed Web of Science ®Google Scholar
• Jayaram P, Mitchell PJT, Shybut TB, Moseley BJ, Lee B. Leukocyte-rich platelet-rich plasma is predominantly anti-inflammatory compared with leukocyte-poor platelet-rich plasma in patients with mild-moderate knee osteoarthritis: a prospective, Descriptive Laboratory Study. Am J Sports Med. 2023;51(8):2133–2140. doi:10.1177/03635465231170394
   PubMed Web of Science ®Google Scholar
• Fadadu PP, Mazzola AJ, Hunter CW, Davis TT. Review of concentration yields in commercially available platelet-rich plasma (PRP) systems: a call for PRP standardization. Reg Anesth Pain Med. 2019;44(6):652–659. doi:10.1136/rapm-2018-100356
   Web of Science ®Google Scholar
• Dhurat R, Sukesh M. Principles and methods of preparation of platelet-rich plasma: A Review and Author’s Perspective. J Cutan Aesthet Surg. 2014;7(4):189–197.
   PubMedGoogle Scholar
• Croise B, Pare A, Joly A, Louisy A, Laure B, Goga D. Optimized centrifugation preparation of the platelet rich plasma: literature review. J Stomatol Oral Maxillofac Surg. 2019;2019:1.
   Google Scholar
• Arora S, Doda V, Kotwal U, Dogra M. Quantification of platelets and platelet derived growth factors from platelet-rich plasma (PRP) prepared at different centrifugal force (g) and time. Transfus Apher Sci. 2016;54:103–110. doi:10.1016/j.transci.2016.01.028
   PubMed Web of Science ®Google Scholar
• Alio L, Arnalich-Montiel J, F E, Rodriguez A. The role of “eye platelet rich plasma” (E-Prp) for wound healing in ophthalmology. Curr Pharm Biotechnol. 2012;13(7):1257–1265. doi:10.2174/138920112800624355
   PubMed Web of Science ®Google Scholar
• Jung JU, Hee Lee S, Kyun Kim H. Effects of platelet-rich plasma on ocular surface in patients with dry eye syndrome: clinico-experimental analysis. J Korean Ophthalmol Soc. 2019;60:1169–1175. doi:10.3341/jkos.2019.60.12.1169
   Web of Science ®Google Scholar
• Mazzocca AD, McCarthy MB, Chowaniec DM, et al. Platelet- rich plasma differs according to preparation method and human variability. J Bone Joint Surg Am. 2012;94:308–316. doi:10.2106/JBJS.K.00430
   PubMed Web of Science ®Google Scholar
• Rubak P, Nissen PH, Kristensen SD, Hvas AM. Investigation of platelet function and platelet disorders using flow cytometry. Platelets. 2016;27(1):66–74. doi:10.3109/09537104.2015.1032919
   PubMed Web of Science ®Google Scholar
• Pik W, Diaz R, Borg-Stein J. Platelet-rich plasma. Phys Med Rehabil Clin N Am. 2016;27(4):825–853. doi:10.1016/j.pmr.2016.06.002
   PubMed Web of Science ®Google Scholar
• Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85(6):638–646. doi:10.1016/S1079-2104(98)90029-4
   PubMed Web of Science ®Google Scholar
• Amable PR, Carias RB, Teixeira MV, et al. Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Res Ther. 2013;4:67–74. doi:10.1186/scrt218
   PubMed Web of Science ®Google Scholar
• Nadelmann Jennifer B, Bunya VY, Ying G-S, et al. Effect of autologous platelet-rich plasma drops in the treatment of ocular surface disease. Clin Ophthalmol. 2022;16:4207–4213. doi:10.2147/OPTH.S391536
   PubMed Web of Science ®Google Scholar
• Panda BB, Mohapatra S, Parida S. Update on the role of Eye Platelet-Rich Plasma (E-PRP) in the treatment of ocular surface disorders. Indian J Clin Exp Ophthalmol. 2020;6:487–496. doi:10.18231/j.ijceo.2020.106
   Google Scholar
• Kobayashi Y, Saita Y, Nishio H, et al. Leukocyte concentration and composition in platelet-rich plasma (PRP) influences the growth factor and protease concentrations. J Orthop Sci. 2016;21:683–689. doi:10.1016/j.jos.2016.07.009
   PubMed Web of Science ®Google Scholar
• Perez AG, Lana JF, Rodrigues AA, Luzo AC, Belangero WD, Santana MH. Relevant aspects of centrifugation step in the preparation of platelet-rich plasma. ISRN Hematol. 2014;2014:176060. doi:10.1155/2014/176060
   PubMedGoogle Scholar
• Dohan DM, Choukroun J, Diss A, et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(3):45–50. doi:10.1016/j.tripleo.2005.07.009
   PubMed Web of Science ®Google Scholar
• Fijnheer R, Pietersz RN, de Korte D, et al. Platelet activation during preparation of platelet concentrates: a comparison of the platelet‐rich plasma and the buffy coat methods. Transfusion. 1990;30:634–638. doi:10.1046/j.1537-2995.1990.30790385523.x
   PubMed Web of Science ®Google Scholar
• Bramanti E, Benedetti E, Sagripanti A, Papineschi F, Benedetti E. Determination of secondary structure of normal fibrin from human peripheral blood. Biopolymers. 1997;41(5):545–553. doi:10.1002/(SICI)1097-0282(19970415)41:5<545::AID-BIP6>3.0.CO;2-M
   PubMed Web of Science ®Google Scholar
• Sathian J, Sastry TP, Suguna L, Lakshminarayana Y, Radhakrishnan G. Fibrin as a matrix for grafting 2-hydroxyethyl methacrylate: preparation and characterization of the graft and its in vivo evaluation for wound healing. J Biomed Mater Res A. 2003;65(4):435–440. doi:10.1002/jbm.a.10489
   PubMed Web of Science ®Google Scholar
• Anitua E, Padilla S, Prado R, Alkhraisat MH. Platelet-rich plasma: are the obtaining methods, classification and clinical outcome always connected? Regen Med. 2022;17(12):887–890. doi:10.2217/rme-2022-0118
   PubMed Web of Science ®Google Scholar
• Dohan Ehrenfest DM, Bielecki T, Jimbo R, et al. Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte and platelet-rich fibrin (L-PRF). Curr Pharm Biotechnol. 2012;13(7):1145–1152. doi:10.2174/138920112800624382
   PubMed Web of Science ®Google Scholar
• Isobe K, Watanebe T, Kawabata H, et al. Mechanical and degradation properties of advanced platelet-rich fibrin (A-PRF), concentrated growth factors (CGF), and platelet-poor plasma-derived fibrin (PPTF). Int J Implant Dent. 2017;2017:1–6.
   Google Scholar
• Miron RJ, Zucchelli G, Pikos MA, et al. Use of platelet-rich fibrin in regenerative dentistry: a systematic review. Clin Oral Investig. 2017;21:1913–1927. doi:10.1007/s00784-017-2133-z
   PubMed Web of Science ®Google Scholar